This paper from Brazil looks at polidocanol foam, comparing the Tessari and the double syringe technique and whether cooling has an effect on foam stability. Creation of a stable foam could potentially lead to better treatment outcomes. If beneficial, the use of cooled foam would have minimal cost implications in clinical practice and could be easily and widely adopted. Reviewer: Zola Mzimba, Board Member, BAS

This recently published randomised controlled trial investigates the efficacy of ultrasound-guided foam sclerotherapy (UGFS) directed at distal venous reflux in the management of venous leg ulcers (VLUs). Advancing the standards of VLU care remains central to the mission of the BAS.

Approaching Leg Ulcers: A Comprehensive Overview by Jeremy Crane Jeremy Crane, a Transplant and Vascular Surgeon at Imperial College Healthcare NHS Trust, presented a detailed overview of his approach to managing leg ulcers at the BAS 2024 Meeting. His talk highlighted the significant burden of wounds on the NHS, emphasised accurate diagnosis and nuanced treatments. FREE TO BAS MEMBERS

Average v Excellent Sclerotherapy: The Essential Difference Philip Coleridge Smith, President of the British Association of Sclerotherapists, highlights the crucial distinctions between average and excellent sclerotherapy. While seemingly straightforward, effective sclerotherapy requires meticulous patient selection, thorough examination, appropriate techniques, and realistic patient management. FREE TO BAS MEMBERS

If you want to stand out from the crowd, this essential information is for you. So what is a brand? It's the sum total of all the perceived emotional and functional aspects of a product or a service, okay? So it's not a product, it's a whole thing, it's a whole experience. it's not just a strap line or a logo, it's a feeling. Mike Watkins offers his unique and highly actionable tips on creating your brand.

Alastair Lewis, BAS Chairman, shares his presentation to the 2025 Venous Forum, addressing the considerations surrounding the evidence against foam sclerotherapy and emphasises the importance of careful evaluation. He also outlines his strategies for achieving optimal outcomes after foam sclerotherapy and discusses how to approach challenging cases. Complete the Quiz for a CPD Certificate. FREE TO BAS MEMBERS

Managing the Patient Experience after Venous Surgery: Key Insights from Alastair Lewis Alastair Lewis, a Consultant Venous Surgeon and Chairman of the British Association, delivered a presentation at BAS 2024, emphasising the critical role of managing the patient experience in venous surgery. Lewis highlights that "you don't get a second chance to make a first impression." FREE TO BAS MEMBERS

Emma Kelliher discusses the high profitability and scalability of Microsclerotherapy. She presents it as a business-savvy choice for clinics due to its high-profit margin (88%), low consumable costs, and high demand. Actionable business insights from a successful clinic owner with a turnover of over £1 million. Real-world strategies on marketing, pricing, and treatment packages for long-term business growth.

Dr. Richard Oliver, Head of Technical and Clinical at STD Pharmaceutical Products Ltd., delivers a presentation on the basic science of sclerosants and strategies to mitigate adverse events in sclerotherapy. His talk aimed to clarify common queries encountered at exhibitions and provide practical advice for clinicians. Ful video of the presentation with a PDF comprehensive commentary and summary. FREE TO BAS MEMBERS